First $1B Quarter, Rule of 40 = 94, $10B Army Deal: A Phenomenal Print Into a 100x Sales Multiple — Initiating at Hold

Results vs. Consensus

Q2 2025 was a clean, broad-based beat against both Street consensus and Palantir's own prior guidance. The magnitude of the revenue beat (~7% above the Street midpoint) was roughly 2x the typical Palantir beat cadence (Q1 2025 was a modest beat of ~3%) and is the largest dollar beat the company has printed since 2023.

Quality of the Beat

• Revenue: Fully organic. No acquisitions in the period. International FX was a small tailwind but immaterial. Strategic commercial contracts (the SPAC-era investment vehicle revenue that previously distorted comparisons) contributed only $5.1M and management guides full-year strategic-contract revenue to "less than 0.5% of revenue" — meaning the +48% YoY growth is essentially all underlying enterprise demand. Excluding strategic contracts, total revenue grew +49% YoY and U.S. Commercial grew +95% YoY. Quality is unimpeachable.
• Margins: The 300 bps adjusted operating margin beat vs. guide is a function of continued operating leverage on rev growth far exceeding hiring growth. Adjusted gross margin held at 82% (in line with prior). The operating margin beat is incremental margin economics, not a one-time tailwind. The CFO did flag that Q3 will see a "significant ramp in expenses... due to the seasonality of new hire starts" — meaning Q2's 46% adj OI margin is not the new run-rate, but the FY25 implied adj OI margin (raised guide of $1.916B / $4.146B = 46.2%) confirms the second-half margin will average near current levels. This is structural, not one-time.
• EPS: The $0.16 adjusted EPS beat is operationally driven. Stock-based compensation of $160M in the quarter was up modestly YoY (+13%) but well below the 48% revenue growth, which is a positive read on dilution. Interest income contributed $56M (vs. $47M YoY) on the $6B Treasury portfolio — this is a real but rate-dependent tailwind that will fade if the Fed cuts. Net of stock comp ($160M) and payroll taxes on stock comp ($35M), GAAP net income of $327M is the right way to think about underlying earning power: ~$0.13 GAAP EPS, ~$1.30 annualized run rate against a $173 stock price = ~133x trailing GAAP earnings.
• FCF: $569M of adjusted FCF on $1.004B of revenue is a 57% FCF margin — among the highest in software at any scale. Cash from operations was $539M. Working capital was a modest tailwind (deferred revenue grew $117M sequentially), but the underlying conversion is real: this business is now a structural cash machine. With $6B of cash + Treasuries on the balance sheet and ~$899M remaining on the buyback authorization, capital allocation flexibility is high.

Segment Performance

U.S. Commercial — The Story of the Quarter

U.S. Commercial revenue of $306M (+93% YoY) is the print that defines the quarter and arguably the year. The growth rate accelerated from ~+71% in Q1 2025 to +93% in Q2, and the leading indicators — TCV ($843M, +222% YoY), customer count (485, +64% YoY), and 12-month trailing TCV ($2.8B, +141% vs. prior 12 months) — suggest the acceleration has further to run. The U.S. Commercial RDV (a leading indicator of contracted future revenue) grew 145% YoY to $2.79B. Crucially, NDR was 128%, up 400 bps QoQ — meaning existing customers are expanding at a 28% net rate even before counting new customer adds.

The qualitative texture from the call is even more striking than the numbers. Ryan Taylor cited three customer cases — Citibank cutting customer onboarding/KYC from 9 days to "seconds," Fannie Mae cutting mortgage fraud detection from 2 months to seconds, and Nebraska Medicine reporting "2,100% increase in discharge lounge utilization" — that all read as production-grade, mission-critical AIP deployments rather than the experimental boot camps that characterized 2023–2024. The healthcare customer signing an $88M TCV deal one month after a boot camp is a specific data point for what the AIP land-and-expand motion now looks like at scale.

"Our primary sales force now, and I think likely in the future, are going to be current customers telling other customers." — Alex Karp, CEO

Assessment: The U.S. Commercial business has clearly broken out of the "bumpy because deals are lumpy" pattern that defined 2022–2024 and into a phase where AIP is creating its own pipeline. The fact that growth is accelerating at $1.2B+ ARR scale is what justifies the multiple expansion the stock has received YTD. The risk — not visible in this print — is that the cadence is now so far ahead of the Street that any normalization toward 60–70% U.S. Commercial growth in 2026 (still excellent in absolute terms) would trigger a multiple compression.

U.S. Government — The $10B Anchor

U.S. Government revenue grew +53% YoY to $426M, a clear acceleration from prior quarters. The headline news, however, is the post-quarter (announced on the call) award of a 10-year enterprise agreement with the U.S. Army, "consolidating 75 contracts into a single contract" with a ceiling of up to $10B. Combined with the $795M Maven ceiling increase and a $218M Space Force delivery order also disclosed on the call, the U.S. Government segment is now anchored by multi-year, high-ceiling agreements that materially derisk the FY26–FY30 revenue trajectory.

Three things are worth noting about the Army EA. First, it is a ceiling, not a guaranteed dollar value — actual revenue depends on draw-down rates that won't be known for several quarters. Second, it consolidates existing contracts, which means a portion of the $10B is replacement of in-flight revenue rather than fully incremental. Third, the structural significance is that the Army has formally selected Palantir as its enterprise software partner for the next decade, which makes Palantir extraordinarily difficult to displace in any future Army modernization initiative. The strategic value materially exceeds the in-quarter revenue impact.

Assessment: The U.S. Government segment remains the steady-Eddie compounder underwriting the higher-volatility commercial business. With an accelerating organic growth rate and two flagship multi-year wins, the segment has shifted from "important" to "structurally locked-in" for at least the rest of the decade.

International — The Drag

International commercial revenue declined 3% YoY to $144M — the only obvious soft spot in the quarter. Management's framing is consistent: international commercial is being deliberately deprioritized to redirect FDE (forward-deployed engineer) capacity to the higher-velocity U.S. market. International government, by contrast, grew +37% YoY to $127M, primarily on continued UK strength.

Assessment: The international commercial weakness is a deliberate strategic choice, not a demand problem — but it is also a vulnerability that competitors (notably Microsoft Fabric/Azure Data, Snowflake, Databricks) could exploit to lock in European commercial accounts. We will be watching whether international commercial returns to growth in 2026 or remains a structural drag.

Key KPIs

Almost every leading indicator inflected sharply higher this quarter. The 400 bps sequential improvement in NDR to 128% is particularly notable because NDR by construction excludes new customers acquired in the trailing 12 months — meaning the existing customer base is expanding faster, which is the leading edge of the next 12 months of revenue growth. The $843M U.S. Commercial TCV (+222% YoY) is the single most important leading indicator: at reasonable conversion rates, it implies U.S. Commercial revenue growth remains in the 70–90% range through at least mid-2026.

Key Topics & Management Commentary

Overall Management Tone: Triumphant verging on combative. Karp's prepared remarks and Q&A were noticeably more direct than prior quarters about "haters," "analysts who have been wrong," and the broader cultural/political stance of the company. The financial messaging from CFO Glazer was disciplined, clean, and unusually generous on guidance — the largest single-quarter guidance raise in company history is the strongest possible signal that management has high confidence the H2 trajectory holds. The combination of a swaggering CEO with a methodical CFO is, on balance, a positive read — but the tone shift is worth monitoring for whether it begins to spook the more institutional component of the shareholder base.

1. Ontology as the Real Product (vs. LLMs as Commodity)

The dominant strategic message of the quarter, articulated repeatedly across Karp, Sankar, and Taylor, was that LLMs in isolation are not enterprise-ready and that Palantir's ontology layer is the indispensable bridge between raw model capability and production deployment. This is not new positioning — it has been Palantir's pitch for two years — but the framing has hardened. Sankar's articulation of "Ontology Web Services" as a re-platforming opportunity is materially more ambitious than prior commentary, suggesting Palantir is positioning AIP as the foundational layer competing directly with hyperscaler PaaS for AI-native software.

"LLMs simply don't work in the real world without Palantir. This is the reality fueling our growth." — Ryan Taylor, CRO

"AIP isn't just software our customers use, it's software our customers are building their software on. Software companies are re-platforming away from the highly unopinionated services and building blocks of the hyperscaler stack onto AIP…" — Shyam Sankar, CTO

Assessment: The ontology-as-moat thesis is now backed by hard customer evidence (TeleTracking re-platforming was the named example, with management referencing inbound CEO/CIO inquiries as a result). If Palantir can credibly attack hyperscaler PaaS share, the addressable market expands by an order of magnitude — but this is also where the competitive pushback will get most intense as Microsoft, Google, and AWS all have strong incentives to defend their own application-platform layers. The strategic bet is right; the execution risk is real.

2. Product-Led Growth Without a Direct Sales Force

Wedbush analyst Dan Ives asked the most pointed question on the call: how is Palantir generating this kind of growth without building a traditional direct sales force? Karp's answer was a clear articulation of strategic intent — current customers telling other customers, FDE-led implementations, and minimal traditional sales overhead. The financial implication is meaningful: S&M expense grew only 24% YoY against revenue growth of 48%, generating ~13 points of operating leverage in this line item alone.

"We rejected an idea of like basically the way software is often done… useless product that becomes parasitic, you can't get rid of it and you have 1,000 state dinners, all convince you buy something is useless." — Alex Karp, CEO

Assessment: The S&M efficiency is the structural reason Palantir can sustain a Rule of 40 above 90 even at $4B+ revenue scale. The risk is that as the customer base broadens beyond the existing "true believer" cohort, the product-led motion may need to be augmented with traditional enterprise sales, which would compress margins. Worth monitoring — but not a near-term concern.

3. The Army Ten-Year Enterprise Agreement

The U.S. Army EA "up to $10B over 10 years" consolidating 75 prior contracts into one is the largest single contract action in Palantir's history. Management framed it as the next phase of a long-standing relationship with the Army (a top-three customer for years). The strategic significance is twofold: (1) it positions Palantir as the formal AI/data backbone for the Army's modernization initiatives through 2035; (2) it sets a template for similar enterprise consolidations across other DoD branches and federal civilian agencies.

"Last week, Palantir was awarded a 10-year enterprise agreement with the Army, totaling up to $10 billion, consolidating 75 contracts into a single contract." — Ryan Taylor, CRO

What was not said is also important: management did not provide a near-term draw-down expectation. The $10B is a ceiling, not a forward bookings number, and the actual revenue contribution in any given quarter will depend on task order issuance. Modeling discipline says: do not pull the $10B forward into the model — treat it as a derisked top-end of the U.S. Government revenue trajectory through 2030.

Assessment: Strategically transformative; financially less impactful in the near term than the headline suggests. The right way to think about it: this contract effectively eliminates the bear case that Palantir's government concentration creates contract-renewal risk through the next decade.

4. Maven Smart System — Adoption Doubling Again

Sankar disclosed that Maven usage "doubled in the first 9 months of 2024 and doubled again in the subsequent 5 months. This is on top of that" — suggesting Maven is in a sustained doubling cadence at progressively shorter intervals. The $795M ceiling increase ratifies that growth and presumably reflects DoD demand from combatant commands beyond the initial program scope.

Assessment: Maven has graduated from a single-program win to the de facto AI tasking layer for U.S. military operations. The compounding adoption rate is the leading indicator that Palantir's defense AI position is solidifying, not commoditizing. This is a meaningful tailwind to U.S. Government revenue durability.

5. Profitability Trajectory and Sustained GAAP Earnings

CFO Glazer reiterated the commitment to GAAP operating income and net income in each quarter of FY25 and confirmed Q3 expense seasonality from new hire ramping. The implied second-half adj OI margin (FY25 guide $1.916B less H1 actual $855M = $1.061B in H2 on ~$2.26B in H2 revenue = ~47% margin) is essentially flat-to-up vs. Q2, even with the seasonal hiring ramp. This is the strongest possible signal that the operating leverage is structural and the margin expansion can continue into FY26.

Assessment: The Rule of 40 = 94 print is unprecedented for a public software company at $4B+ ARR. Even allowing for some Q3 seasonality, FY25 implied Rule of 40 of 91 is itself a benchmark-setting figure. The profitability trajectory is no longer the open question.

Guidance & Outlook

This is the largest single-quarter guidance raise in Palantir's public-company history. The FY25 revenue raise of $250M at midpoint reflects approximately $66M of Q2 beat plus ~$184M of upside in H2 (split roughly $96M into Q3 vs. previous Street and ~$88M into Q4). The U.S. Commercial guide raise from ">$1.178B" to ">$1.302B" implies H2 25 U.S. Commercial revenue of approximately $720M (vs. $582M H1 25 actual) — a ~24% sequential ramp that is achievable only if the +93% YoY rate sustains into Q4.

Implied Q3-to-Q4 ramp: FY25 raised guide of $4.146B midpoint less H1 25 actual of $1.888B = $2.258B for H2. With Q3 guided to $1.085B midpoint, this implies Q4 25 of approximately $1.173B (+8% QoQ from Q3) — meaning management is implicitly guiding to another sequential acceleration in Q4. This is the most aggressive H2 ramp Palantir has ever guided to.

Street will likely reset to: FY25 revenue at the high end of the range ($4.15B) and FY26 to ~$5.7–6.0B (vs. ~$5.5B pre-print). At the midpoint of revised FY26 expectations, the stock at $173 trades at ~14x current EV/sales on calendar 2026 — rich vs. most software peers but the only enterprise software name growing 40%+ at this scale.

Guidance style: Historically, Palantir has guided modestly conservatively and beaten consistently. The Q2 guide raise was anything but conservative — it pulls multiple quarters of bull-case forward. This raises the bar for Q3 and Q4: a typical "small beat-and-modest-raise" in November will likely be received as a deceleration vs. the trajectory implied in this print. The "blowout-and-raise" cadence has now been set as the expectation, which is itself a risk factor.

Analyst Q&A Highlights

Topic: Sales-Force Strategy & Growth Sustainability

• Daniel Ives, Wedbush: Asked how Palantir generates this growth without a direct sales force and whether the company will eventually need to build one. Karp’s response was substantive and lengthy: customers selling to customers, FDE-led implementations, leverage from the AI revolution making CIOs proactively reach out. The implication is that S&M leverage is a structural feature, not a temporary one.
  Assessment: Important confirmation that the operating margin trajectory is not predicated on a future S&M build-out that would compress margins.

Topic: AI Action Plan & Talent

• Mariana Perez Mora, Bank of America: Asked about the White House AI Action Plan and Palantir's role, plus how the company is winning the talent war. Sankar pointed to "American open AI tech stack" support, while Karp emphasized agency, mission, and that Palantir has become "the most important credential in tech."
  Assessment: Talent retention is structurally important for Palantir's FDE-heavy model. The fact that Palantir is treating talent as a brand-as-credential is a defensible and somewhat unique moat — if it holds.

Topic: U.S. Commercial Acceleration Sustainability

Multiple analysts probed whether the +93% U.S. Commercial growth rate is sustainable. Management did not commit to specific 2026 segment guidance but pointed to: (1) RDV up 145% YoY and 20% QoQ; (2) NDR rising to 128%; (3) the AIP boot camp pipeline continuing to generate large deals on short conversion cycles. The implicit message: 2026 U.S. Commercial growth should remain elevated, though management understandably declined to commit to a specific rate.

What They're NOT Saying

1. No FY26 preliminary framing. Palantir traditionally provides FY+1 framing only on the Q4 call, which is appropriate, but the guide-up cadence in this print would have allowed for a directional comment on 2026 U.S. Commercial growth. The silence is conservative posture, not concerning — but it leaves the Street to model it independently, which means Q3 print will have to confirm the trajectory.
2. No quantification of the Army EA draw-down rate. The $10B ceiling is impressive; what is the expected annual revenue contribution? Management deliberately framed it as ceiling-not-floor. This is appropriate caution but means the Street will model a wide range, creating volatility around any future Army-related disclosures.
3. No commentary on Microsoft Fabric / Databricks competitive dynamics. The hyperscaler PaaS attack is the most credible bear-case narrative; Palantir's response is to demonstrate AIP wins through customer testimonials, but management did not directly engage the head-to-head competitive question. As long as growth remains in the 90%+ range in U.S. Commercial, this is a non-issue — but if growth normalizes to 50–60% in 2026, the competitive question will move front and center.
4. No update on international commercial restructuring or strategic intent. International commercial declined 3% YoY for the second consecutive quarter. Management's "deliberately deprioritized" framing is fine, but at some point a credible re-engagement plan needs to be articulated — otherwise European competitors will lock in the long-cycle enterprise wins that Palantir is forfeiting.
5. No comment on stock-based compensation trajectory. SBC of $160M in the quarter is up only +13% YoY against +48% revenue growth, which is a positive trajectory — but the dollar level is still meaningful (~16% of revenue) and management has not yet articulated a long-term SBC-as-percent-of-revenue target. This will become more important as the growth rate naturally normalizes over time.

Market Reaction

• Pre-print close (Aug 1, Friday): $154.27
• Day-of-print close (Aug 4, Monday): $160.66 (+4.1% intraday on positioning into the print)
• After-hours reaction (Aug 4, post-press release / call): roughly +3 to +4% in extended trading
• T+1 close (Aug 5, Tuesday — cutoff): $173.27 (+7.85% on the day; +12.3% from Aug 1 last pre-print close)
• T+1 volume: 130.9M shares (~1.6x the trailing 5-day average)
• Implied market cap at $173.27: ~$416B on ~2.4B diluted shares

The +7.85% T+1 move is meaningfully larger than the +3 to +4% initial after-hours reaction — which tells you the buy-side digested the magnitude of the FY25 raise overnight and concluded the print breaks the "beat-and-fade" pattern that haunted Q1 2025. The volume on Aug 5 (130.9M shares, ~1.6x the trailing 5-day average) signals genuine institutional accumulation, not just retail re-engagement.

Street Perspective

Debate: Is the U.S. Commercial Growth Curve Sustainable Through 2026?

Bull view: RDV +145% YoY and TCV +222% YoY are leading indicators that imply U.S. Commercial revenue can stay above 75% YoY growth through at least mid-2026. The AIP boot camp pipeline is converting at unprecedented rates, NDR is rising not falling, and customer count is still growing 64% YoY. The bull case is that the U.S. Commercial business is in the early innings of a 3–5 year hyper-growth phase that supports a sustained premium multiple.

Bear view: The +93% growth rate is mathematically unsustainable as the base scales. Even on the most optimistic conversion of the $843M U.S. Commercial TCV booked this quarter, the law of large numbers will compress growth toward 50–60% by H2 2026. The current multiple discounts none of that natural deceleration. Once growth begins to normalize, the multiple will compress regardless of underlying business quality.

Our take: The bear is mathematically correct that the rate must decelerate; the bull is right that the deceleration cliff is several quarters away. The next twelve months are likely to be supportive of the multiple as Palantir continues to print 70%+ U.S. Commercial growth. The risk is in calendar Q3 2026 and beyond, when the comp gets exceptionally hard. Owning PLTR through the next two earnings prints is reasonable; owning it on a 24-month view requires belief that AIP can sustain growth through a much harder comp set.

Debate: Does the Government Concentration Cap or Anchor the Multiple?

Bull view: The $10B Army EA, $795M Maven ceiling lift, and $218M Space Force order all secure the U.S. Government revenue line through 2030, derisking the multi-year forecast. With 53% YoY government growth at current scale, the segment is a steady compounder that justifies a higher multiple than typical govtech businesses receive.

Bear view: Government revenue concentration creates customer-concentration risk (single contract events can move quarterly numbers) and political risk (administration changes, defense spending cycles, congressional scrutiny). The recent Karp public-stance comments could become a flashpoint with a future administration. Long-cycle DoD contracts also tend to compress margins over time as competitors enter recompetitions.

Our take: At the current scale, the U.S. Government segment is more anchor than risk — the ten-year Army EA effectively eliminates the "contract recompete cliff" bear case. We disagree with the political-risk framing — Palantir's operational utility is bipartisan in practice, and the Army EA was approved under the current political environment, not in spite of it.

Debate: Is the Valuation Defensible?

Bull view: At ~14x EV/sales on calendar 2026 (~$5.8B), PLTR is expensive but not unprecedented — Snowflake traded at 30x+ in 2021, ServiceNow has consistently held 12–15x. The Rule of 40 = 94 print justifies a "best-in-class" multiple, and the FCF margin (57% in Q2) is among the highest in software. On a discounted cash flow basis, modest assumptions about multi-year FCF growth (25–30% CAGR through 2030) support the current price.

Bear view: ~100x forward sales and ~210x adjusted FCF guide are not sustainable by any historical software valuation framework. Even Snowflake at peak 2021 traded at ~80x forward sales on faster growth and a longer runway. The current PLTR multiple bakes in a perfect-execution scenario through at least 2027; any normalization of growth (which is mathematically inevitable) would justify a 30–50% multiple compression.

Our take: We side with the bear on valuation arithmetic — but acknowledge the bull is winning the trade in the near term. The right framing: PLTR is a great business at a price that requires you to be right not only about the next 12 months but about the next 36 months of accelerated execution. We would rather wait for a better entry point than chase the post-print rally. This is the core reason for the Hold rating.

Model Implications

This is initiating coverage; we are standing up the historical model and projections from scratch (10-K FY24 + 10-Q Q1 25 + Q2 25 8-K). Key calibration anchors after Q2:

• FY25 revenue: Anchor at the high end of guide ($4.150B). Q2 actual + Q3 guide implies H2 weighted toward Q4 ramp; we model FY25 at $4.155B (+45.3% YoY).
• FY26 revenue: Model 38–42% YoY growth to $5.75–5.90B. U.S. Commercial assumed +70% YoY (deceleration from +85% FY25), U.S. Government +35% (modest accel from continued Army/Maven draw-down), International Commercial flat to +5%, International Government +25%.
• Adjusted operating margin: FY25 at 46% (per guide), FY26 at 47–48% as operating leverage continues. The structural ceiling is probably ~50% — further margin expansion beyond that would require slowing FDE hiring, which would compress the growth rate.
• Adjusted FCF margin: FY25 at ~46% (guide midpoint $1.9B / $4.146B). FY26 model 48–50% as deferred revenue cadence continues to support cash conversion.
• Stock-based compensation: FY25 SBC modeled at ~$680M (vs. $315M H1 actual). FY26 modeled at ~$800M (~14% of revenue, declining 200 bps YoY).
• Diluted share count: Currently 2.56B; assume +2% annual growth net of buybacks against the $899M remaining authorization.
• Valuation framework: Sum-of-the-parts — U.S. Commercial deserves 18–22x forward sales (best-in-class growth), U.S. Government 8–10x (steady compounder), International blended 5–7x. Blended fair value ~12–14x forward sales. At $173, PLTR is 1–2 turns above our fair-value range.
• 12-month price target: $145 (range $115–$175). Below current price but reflects our valuation discipline. We would upgrade the rating before the price target on improved entry-point risk/reward.

Thesis Scorecard Post-Earnings

Overall: Operating thesis decisively confirmed and strengthened. Valuation thesis remains the single binding constraint. The print materially derisks the FY25 numbers and partly derisks FY26, but it does not solve for multi-year multiple compression risk.

Action: Initiating at Hold. We want to own this business; we do not want to own it at $173. Patient capital should wait for one of two scenarios: (a) a 20–25% drawdown on macro or rotation rather than fundamental impairment, which would create a high-conviction Outperform entry; or (b) one additional quarter of evidence (Q3 2025 print, expected November) that the +90% U.S. Commercial trajectory is durable into 2026, which would justify upgrading at a higher absolute price level.